Star Lake Bioscience Co., Inc.Zhaoqing Guangdong

¥4.28As of Sun 8 Nov 2026, 12:00 UTC
SSE:600866Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (2.53%)
Div yield 8.88%
ROE 0.30%
Biotechnology
Beta (5Y) 0.10
PE TTM 361.9
TSR TTM (35.67%)
Mkt cap ¥7.111B
ROIC 0.25%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥4.42
3.38%
(56.24%)
Hold 11|2|6|12|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.05
0.05
0.05
0.06
22.69%
25.52%
27.22%
46.94%
Revenue¥M
488.9
480.4
494.7
515.9
6.96%
6.43%
7.36%
6.68%
Peers (US$1.066B)
Cap (US$)
PE
1.086B
26.50x
1.060B
—
Capital
TTM
5Y
10Y
Leveragex
1.329
0.935
0.821
EBIT/Intx
0.376
0.217
0.211
Own earn%
4.23
113.59
113.93
Sh yield%
26.23
39.73
42.67
Owners
Insiders/Inst%
12.22
61.13
Short interest%
4.55
SBC / revenue%
2.64
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
12–18
$1 testx
—
Incr. ROIC%
1